Abstract
The main target organ of the mycotoxin ochratoxin A (OTA) in mammals is the kidney but OTA has also been shown to be hepatotoxic in rats and to induce tumors in mouse liver. Even at very low concentrations, OTA causes perturbations of cellular signaling pathways as well as enhanced apoptosis. OTA has been extensively studied in kidney cell systems. Since this substance also affects liver health, we focused our work on apoptosis-related events induced by OTA in primary rat hepatocytes. We performed pathway-specific polymerase chain reaction arrays to assess the expression of genes involved in apoptosis. Treatment with 1 µM OTA for 24 h caused marked changes in apoptosis-related gene expression. Genes as apaf1, bad, caspase 7, polb (DNA polymerase beta, performs base excision repair), and p53, which are marker genes for DNA damage, were upregulated. FAS and faslg were also markedly induced by treatment with OTA. Treatment of hepatocytes with OTA led to a concentration-dependent inhibition of protein biosynthesis. Apoptosis-inducing factor was released from mitochondria following OTA treatment; the mycotoxin induced the activity of caspases 8, 9, and 3/7 and caused chromatin condensation and fragmentation. Caspase inhibition led to a significant but not complete reduction of OTA-induced apoptosis. Our data suggest that not only OTA leads to p53-dependent apoptosis in rat hepatocytes but it also hints to other mechanisms, independent of caspase activation or protein biosynthesis, being involved.
Similar content being viewed by others
Abbreviations
- AIF:
-
Apoptosis-inducing factor
- CAD:
-
Caspase-activated DNase
- CHX:
-
Cycloheximide
- DAPI:
-
4′, 6-Diamidino-2-phenylindole
- DMSO:
-
Dimethyl sulfoxide
- DTT:
-
Dithiothreitol
- DFF:
-
DNA fragmentation factor
- ICAD:
-
Inhibitor of caspase-activated DNase
- OTA:
-
Ochratoxin A
- PIPES:
-
Piperazine-N,N′-bis(2-ethanesulfonic acid)
- PBS:
-
Phosphate-buffered saline
- PVDF:
-
Polyvinylidene fluoride
- qPCR:
-
Quantitative polymerase chain reaction
- ROS:
-
Reactive oxygen species
- c T :
-
Threshold cycle
- TBS:
-
Tris-buffered saline
- VDAC:
-
Voltage-dependent anion channel
References
Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science. 1998;281:1322–6.
Al-Anati L, Katz N, Petzinger E. Interference of arachidonic acid and its metabolites with TNF-α release by ochratoxin A from rat liver. Toxicology. 2005;208:335–46.
Alessenko AV, Boikov P, Filippova GN, Khrenov AV, Loginov AS, Makarieva ED. Mechanisms of cycloheximide-induced apoptosis in liver cells. FEBS Lett. 1997;416:113–6.
Assaf H, Azouri H, Pallardy M. Ochratoxin A induces apoptosis in human lymphocytes through down regulation of Bcl-xL. Toxicol Sci. 2004;79:335–44.
Atroshi F, Biese I, Saloniemi H, Ali-Vehmas T, Saari S, Rizzo A, et al. Significance of apoptosis and its relationship to antioxidants after ochratoxin A administration in mice. J Pharm Pharmaceut Sci. 2000;3:281–91.
Basu A, Haldar S. The relationship between Bcl2, Bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod. 1998;4:1099–109.
Bennett JW, Klich M. Mycotoxins. Clin Microbiol Rev. 2003;16:497–516.
Blom WM, de Bont HJGM, Meijerman I, Mulder GJ, Nagelkerke JF. Prevention of cycloheximide-induced apoptosis in hepatocytes by adenosine and by caspase inhibitors. Biochem Pharmacol. 1999;58:1891–8.
Boesch-Saadatmandi C, Loboda A, Jozkowicz A, Huebbe P, Blank R, Wolffram S, et al. Effect of ochratoxin A on redux-regulated transcription factors, antioxidant enzymes and glutathione-S-transferase in cultured kidney tubulus cells. Food Chem Toxicol. 2008;46:2665–71.
Bouaziz C, Sharaf el dein O, El Golli E, Abid-Essefi S, Brenner C, Lemaire C, et al. Different apoptotic pathways induced by zearalenone, T-2 toxin and ochratoxin A in human hepatoma cells. Toxicology. 2008;254:19–28.
Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.
Budihardjo I, Oliver H, Lutter M, Luo X, Wang X. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol. 1999;15:269–90.
Cote J, Ruiz-Carrillo A. Primers for mitochondrial DNA replication generated by endonuclease G. Science. 1993;261:765–9.
Dai J, Park G, Perry JL, Il’ichev YV, Bow DAJ, Pritchard JB, et al. Molecular aspects of the transport and toxicity of ochratoxin A. Acc Chem Res. 2004;37:874–81.
Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116:205–19.
Delatour T, Mally A, Richoz J, Özden S, Dekant W, Ihmels H, et al. Absence of 2′-deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC–MS/MS. Mol Nutr Food Res. 2008;52:427–82.
Dirheimer G, Creppy EE. Mechanism of action of ochratoxin A. IARC Sci Publ. 1991;115:171–86.
Dörrenhaus A, Föllmann W. Effects of ochratoxin A on DNA repair in cultures of rat hepatocytes and porcine urinary bladder epithelial cells. Arch Toxicol. 1997;71:709–13.
Dragan YP, Bidlack WR, Cohen SM, Goldsworthy TL, Hard GC, Howard PC, et al. Implications of apoptosis for toxicity, carcinogenicity, and risk assessment: fumonisin B1 as an example. Toxicol Sci. 2001;61:6–17.
Föllmann W, Lucas S. Effects of the mycotoxin ochratoxin A in a bacterial and a mammalian in vitro mutagenicity test system. Arch Toxicol. 2003;77:298–304.
Fornace AJ Jr, Zmudzka B, Hollander MC, Wilson SH. Induction of β-polymerase mRNA by DNA-damaging agents in Chinese hamster ovary cells. Mol Cell Biol. 1989;9:851–3.
Fortin A, Cregan SP, MacLaurin JG, Kushwaha N, Hickman ES, Thompson CS, et al. APAF1 is a key transcriptional target for p53 in the regulation of neural cell death. J Cell Biol. 2001;155:207–16.
Gagliano N, Doone ID, Torri C, Migliori M, Grizzi F, Milzani A, et al. Early cytotoxic effects of ochratoxin A in rat liver: a morphological, biochemical and molecular study. Toxicology. 2006;225:214–24.
Gekle M, Sauvant C, Schwerdt G. Ochratoxin A at nanomolar concentrations: a signal modulator in renal cells. Mol Nutr Food Res. 2005;49:118–30.
Helinek TG, Devlin TM, Ch’ih JJ. Initial inhibition and recovery of protein synthesis in cycloheximide-treated hepatocytes. Biochem Pharmacol. 1982;31:1219–25.
International Agency for Research on Cancer. The evaluation of carcinogenic risks to human. IARC Monographs 56. Lyons: IARC; 1997.
Ishihara Y, Shimamoto N. Involvement of endonuclease G in nucleosomal DNA fragmentation under sustained endogenous oxidative stress. J Biol Chem. 2006;281:6726–33.
Ito K, Kiyosawa N, Kumagi K, Manabe S, Matsunuma N, Yamoto T. Molecular mechanism investigation of cycloheximide-induced hepatocytes apoptosis in rat livers by morphological and microarray analysis. Toxicology. 2006;219:175–86.
Jackel MC. Die genetische Kontrolle des programmierten Zelltod (Apoptose). HNO. 1998;46:614–25.
Jiang P, Du W, Hesse K, Wu M. The Bad guy cooperates with a good Cop p53: Bad is transcriptionally up-regulated by p53 and forms Bad/p53 complex at the mitochondria to induce apoptosis. Mol Cell Biol. 2006;26:9071–82.
Kamp HG, Eisenbrand G, Schlatter J, Würth K, Janzowski C. Ochratoxin A: induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells. Toxicology. 2005;206:413–25.
Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239–57.
Kulms D, Schwarz T. Independent contribution of three different pathways to ultraviolet-B-induced apoptosis. Biochem Pharmacol. 2002;64:837–41.
Lawen A. Apoptosis—an introduction. Bioassays. 2003;25:888–96.
Luhe A, Hildebrand H, Bach U, Dingermann T, Ahr H-J. A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: expression profiling in vivo and in vitro employing cDNA microarrays. Toxicol Sci. 2003;73:315–28.
MacLachlan TK, El-Deiry WS. Apoptotic threshold is lowered by p53 transactivation of caspase-6. Proc Natl Acad Sci U S A. 2002;9:9492–7.
Mally A, Dekant W. Mycotoxins and the kidney: modes of action for renal tumor formation by ochratoxin A in rodents. Mol Nutr Food Res. 2009;53:467–78. doi:10.1002/mnfr.200800149.
Marin-Kuan M, Nestler S, Verguet C, Bezencon C, Piguet D, Mansourian R, et al. A toxicogenomics approach to identify new plausible epigenetic mechanisms of ochratoxin A carcinogenicity in rat. Toxicol Sci. 2006;89:120–34.
Marin-Kuan M, Cavin C, Delatour T, Schilter B. Ochratoxin A carcinogenicity involves a complex network of epigenetic mechanisms. Toxicon. 2008;52:195–202.
National Toxicology Program. 11th Report on carcinogens, ochratoxin A. 2005
O’Brian J, Wilson I, Orton T, Pognan F. Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem. 2000;267:5421–6.
Obrig TG, Culp WJ, McKeehan WL, Hardesty B. The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. J Biol Chem. 1971;246:174–81.
Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29:2002–7.
Rached E, Pfeiffer E, Dekant W, Mally A. Ochratoxin A: apoptosis and aberrant exit from mitosis due to perturbation of microtubule dynamics? Toxicol Sci. 2006;92:78–86.
Ringot D, Chango A, Schneider Y-J, Larondelle Y. Toxicokinetics and toxicodynamics of ochratoxin A, an update. Chem Biol Interact. 2006;159:18–46.
Ruiz-Carrillo A, Renaud J. Endonuclease G: a (dG)n X (dC)n-specific DNase from higher eukaryotes. EMBO J. 1978;6:401–7.
Samejima K, Earnshaw WC. Thrashing the genome: the role of nucleases during apoptosis. Nat Rev Mol Cell Biol. 2005;6:677–88.
Sauvant C, Holzinger H, Gekle M. The nephrotoxin ochratoxin A induces key parameters of chronic interstitial nephropathy in renal proximal tubular cells. Cell Physiol Biochem. 2005;15:125–34.
Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, et al. Two CD95 (APO-1/Fas) signalling pathways. EMBO. 1998;17:1675–87.
Schilter B, Marin-Kuan M, Delatour T, Nestler S, Mantle P, Cavin C. Ochratoxin A: potential epigenetic mechanisms of toxicity and carcinogenicity. Food Addit Contam. 2005;22(Suppl 1):88–93.
Schimmer AD. Inhibitor of apoptosis proteins: translating basic knowledge into clinical practice. Cancer Res. 2004;64:7183–90.
Schrenk D, Karger A, Lipp HP, Bock KW. 2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin and ethinylestradiol as co-mitogens in cultured rat hepatocytes. Carcinogenesis. 1992;13:453–6.
Schwerdt G, Freudinger R, Mildenberger S, Silbernagl S, Gekle M. The nephrotoxin ochratoxin A induces apoptosis in cultured human proximal tubule cells. Cell Biol Toxicol. 1999;15:405–15.
Scibelli A, Tafuri S, Ferrante MC, Alimenti E, Naso B, Lucisano A, et al. Ochratoxin A affects COS cell adhesion and signaling. Toxicol Appl Pharmacol. 2003;192:222–30.
Seglen PO. Preparation of isolated rat liver cells. Methods Cell Biol. 1976;13:29–83.
Simmons MJ, Fan G, Wong W-X, Degenhardt K, Ehite E, Gelinas C. Bfl-1/A1 functions, similar to Mcl-1, as a selective tBid and Bak antagonist. Oncogene. 2008;27:1421–8.
Temme C, Weissbach R, Lilie H, Wilson C, Meinhart A, Meyer S, et al. The Drosophila melanogaster gene CG4930 encodes a high affinity inhibitor for endonuclease G. J Biol Chem. 2009;284:8337–48.
Widlak P. The DFF40/CAD endonuclease and its role in apoptosis. Acta Biochim Pol. 2000;47:1037–44.
Wörner W, Schrenk D. Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetaminofluorene, ultraviolet light, or transforming growth factor β1. Cancer Res. 1996;56:1272–8.
Yang C, Kaushal V, Haun RS, Seth R, Shah SV, Kaushal GP. Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity. Cell Death Diff. 2008;15:530–44.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chopra, M., Link, P., Michels, C. et al. Characterization of ochratoxin A-induced apoptosis in primary rat hepatocytes. Cell Biol Toxicol 26, 239–254 (2010). https://doi.org/10.1007/s10565-009-9131-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10565-009-9131-0